Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy

Files

Access status: Embargo until 2050-01-01 , 1-s2.0-S0161589004002895-main.pdf (183.24 KB)

Publication date

2005

Authors

Haan, E.
Moret, Ed EISNI 0000000369314238
Wagenaar-Hilbers, J.P.A.
Liskamp, RobISNI 0000000393845493
Wauben, MarcaORCID 0000-0003-0360-0311ISNI 0000000390143250

Editors

Advisors

Supervisors

DOI

Document Type

Article

License

Abstract

Keywords

Farmacie(FARM), Diergeneeskunde (DGNK)

Citation

Haan, E, Moret, E E, Wagenaar-Hilbers, J P A, Liskamp, R M J & Wauben, M H M 2005, 'Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy', Molecular Immunology, vol. 42, no. 3, pp. 365-373.